🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInsurance & AccessMounjaro savings card — manufacturer program changes 2026 Page 2

Mounjaro savings card — manufacturer program changes 2026

MounjBrad Fri, Mar 13, 2026 at 4:36 AM 10 replies 180 viewsPage 2 of 2
BrianDallas92
Member
312
1,456
Oct 2024
Dallas, TX
Mar 13, 2026 at 7:26 AM#6

Great breakdown. I'll add one more hack that most people don't know about:

If you're hitting a coverage gap or your insurance is giving you trouble, call the manufacturer directly and ask about their Bridge Program. Both Lilly and Novo Nordisk have programs for patients who are between insurance plans, waiting for PA approval, or experiencing a temporary coverage disruption. They can sometimes provide free medication for 30-90 days.

The phone numbers:

  • Lilly Patient Support: 1-800-545-6962
  • Novo Nordisk Patient Assistance: 1-866-310-7549

You'll need your prescription and income verification but it's worth the call.

44 12Dr.PathRoch, mona_PHX, andrew_nyc and 41 others
Reply Quote Save Share Report
maya_sedona
Member
289
1,234
Sep 2024
Sedona, AZ
Mar 13, 2026 at 7:43 AM#7

This is all great for people with decent commercial insurance. My situation: small employer plan through UHC. They explicitly exclude ALL anti-obesity medications. No Wegovy, no Zepbound, no Contrave, nothing.

The Zepbound savings card without coverage path gives me $550/month. That's $6,600/year. I make $52K. That's almost 13% of my pre-tax income on one medication.

I ended up going the compounded semaglutide route through a telehealth provider. $149/month. Is it the same as brand? Probably not exactly. But it's working — down 34 lbs in 5 months — and I can actually afford it without choosing between medication and rent.

The system is broken when insurance happily covers the downstream costs of obesity (joint replacements, diabetes meds, cardiac interventions) but won't cover a preventive medication that costs a fraction of those interventions.

Last edited: Mar 13, 2026 at 11:43 AM
10 11NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 7 others
Reply Quote Save Share Report
SurmountFan_IN
Member
789
3,456
May 2024
Indianapolis, IN
Mar 13, 2026 at 8:00 AM#8

I completely agree about the system being broken. For what it's worth, some states are starting to mandate coverage. If you're in a state with pending legislation, it might be worth writing to your state rep.

Updated summary of all the paths discussed in this thread:

  1. Best case: Commercial insurance coverage + savings card = ~$25/mo
  2. Insurance covers but high copay: Savings card brings it down significantly
  3. No insurance coverage: Manufacturer savings card = ~$500-550/mo
  4. Between plans: Bridge programs for temporary free supply
  5. Budget route: Compounded semaglutide via telehealth = ~$100-200/mo
  6. Cash pay retail: $1,069-1,349/mo (avoid this if at all possible)
44 1traveltech_sara, AttorneyGrant, DebRD_ATL and 41 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

Similar Threads

Prior authorization success: step-by-step guide with templates5 replies
Cigna now covering Zepbound — how I got approved13 replies
Appeal letter template — denied PA for GLP-1 medications4 replies
Medicare Part D GLP-1 coverage — what's covered in 202610 replies
Cost comparison: brand vs compounded — comprehensive analysis8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register